Prosecution Insights
Last updated: October 04, 2026

Borden Ladner Gervais LLP (Ottawa)

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

34 pending office actions • 21 clients • 34 examiners • 27 art units • 0 of 34 (0%) have an AI response strategy ready

Analysis

BORDEN LADNER GERVAIS LLP (OTTAWA) focuses its patent prosecution on the Biotechnology & Pharmaceuticals technology area. The firm has managed 2469 career applications in this field. There are 31 pending office actions currently being addressed by the firm's practitioners.

The resolved allowance rate for the firm is 80.1 percent. Prosecution typically involves an average of 3.22 office actions per allowance. This rate and average provide a clear picture of the firm's performance in the biotechnology and pharmaceutical sectors, which often present complex legal and technical challenges. The 31 pending actions indicate a steady flow of work within the USPTO. Practitioners can use the 80.1 percent allowance rate as a benchmark for the firm's success in navigating the examination process. The 3.22 average office actions per allowance across 2469 career applications suggests a persistent approach to securing intellectual property rights in life sciences.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=2469 apps, methodology: how we score firms)

80.1%
Allowance Rate
n=2469
+0.44σ
Allowance Rate (norm)
n=2469
3.2
OAs to Allowance
n=1340
-0.10σ
OAs to Allow (norm)
n=1340
1053 days
Time to Allowance
n=1340
+13.0pp
Interview Lift
n=2469
23.0%
RCE Rate
n=2469
1.3%
Appeal Rate
n=2469

Rejection Performance (% of received rejections ultimately overcome)

70.4%
§101 Overcome
n=176
79.5%
§102 Overcome
n=591
79.0%
§103 Overcome
n=827
81.5%
§112 Overcome
n=623

Specialization & Scale

G06F, H04L, G11C
Top CPC Subclasses
14%
Top-3 CPC Share
n=2469
0
Practitioners
n=2469
—
Apps / Practitioner
n=2469 (min 20)

Portfolio Summary

34
Total Pending OAs
18
Non-Final OAs
12
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
6
Due this month
4
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (6)Due ≤ 60 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

19
Hard (56%)
13
Medium (38%)
2
Easy (6%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (3%)
§101 + other6 (18%)
§103 only9 (26%)
§102 only3 (9%)
§112 only2 (6%)
Double-patenting + other1 (3%)
Multi-statute (no §101)12 (35%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
26% of docket
7
Information Tech
21% of docket
1
Communications
3% of docket
3
Semiconductors
9% of docket
10
Mechanical / Eng
29% of docket
4
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

340 h
Manual time on pending OAs
68 h
Time saved (low, 20%)
119 h
Time saved (mid, 35%)
3.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BOYD, MALA DENAE 1 — —
DUCK, BRANDON M 1 63.4% +18.1%
MCCLEARY, CAITLIN RENEE 1 59.8% +25.3%
TURCHEN, JAMES R 1 82.4% +33.6%
SHENG, CHAO 1 64.4% +26.8%
MALIKASIM, JONATHAN L 1 80.9% -0.8%
PETRITSCH, AMANDA MICHELLE 1 57.1% +28.1%
LYONS, MICHAEL A 1 86.5% +10.0%
COFFA, SERGIO 1 61.1% +32.5%
VU, QUYNH-NHU HOANG 1 68.5% +27.4%

Hard Cases (19)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17602205 RADIOPAQUE GLASS MATERIAL WESTERBERG, NISSA M 126d overdue
17990322 IMPLANTABLE FULLY ENDOVASCULAR MAMMALIAN BODY SUCCEDENT CAVITY WALL BREACH SEALING DEVICE DORNBUSCH, DIANNE 43d overdue
18235469 METHOD AND DEVICE FOR SAMPLE INTRODUCTION FOR MASS SPECTROMETRY KALISZEWSKI, ALINA ROSE 23d overdue
18911655 METHODS AND SYSTEMS FOR PROVIDING CONTROL IN RELATION TO ON-DEMAND FLEET WITH ELECTRIC VEHICLES MCCLEARY, CAITLIN RENEE 9d
18343960 METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES DONOHUE, SEAN R 15d
17979350 METAL-DISSOLVING APPARATUS, PROCESSES AND USES THEREOF PULLEN, NIKOLAS TAKUYA 15d
18634043 SYSTEM AND METHOD FOR DEFECT ROOT CAUSE DETERMINATION AND REPORTING IN A SOFTWARE ENVIRONMENT SCHELL, JOSEPH O 23d
18326537 SYSTEM AND METHOD FOR PROVIDING CYBERSECURITY SIMULATION AND TRAINING BIANCAMANO, ALYSSA N 27d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18911655 METHODS AND SYSTEMS FOR PROVIDING CONTROL IN RELATION TO ON-DEMAND FLEET WITH ELECTRIC VEHICLES MCCLEARY, CAITLIN RENEE 9d
18958377 SYSTEM AND METHOD FOR PROVIDING DATA ACCESS DUCK, BRANDON M —
18897062 SYSTEM AND METHOD FOR AUTHORIZING DATA TRANSFERS TURCHEN, JAMES R —
18892977 INTRALUMINAL MODULAR POWERED MEDICAL SYSTEM SHENG, CHAO —
18784024 GLASS COMPOSITION PETRITSCH, AMANDA MICHELLE —
18728810 ANALYZER SYSTEM AND METHOD FOR REAL-TIME SYNCHRONOUS DETECTION OF THE CHARACTERISTIC NEAR-INFRARED WAVELENGTH FEATURES OF OPTICALLY ACTIVE SUBSTANCES LYONS, MICHAEL A —
18703101 RECOMBINANT POLYPEPTIDE FOR DISRUPTING INTERACTION OF EAG2 AND KVß2 AND THERAPEUTIC APPLICATIONS THEREOF IN CANCER TREATMENT COFFA, SERGIO —
18701047 MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME VU, QUYNH-NHU HOANG —

Client Portfolio (21 clients)

Top Art Units

Art UnitApps
37972
37712
16182
24971
36931
36691
24391
28711
21141
37251

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18965530 SYSTEM AND METHOD FOR AUTOMATED MASKING OF PERSONALLY IDENTIFIABLE INFORMATION DATA The Toronto-Dominion Bank BOYD, MALA DENAE 2497 §102 Non-Final OA — Pending Dec 02, 2024
18958377 SYSTEM AND METHOD FOR PROVIDING DATA ACCESS The Toronto-Dominion Bank DUCK, BRANDON M 3693 §101 Non-Final OA — Pending Nov 25, 2024
18911655 METHODS AND SYSTEMS FOR PROVIDING CONTROL IN RELATION TO ON-DEMAND FLEET WITH ELECTRIC VEHICLES Bluwave Inc. MCCLEARY, CAITLIN RENEE 3669 §101§103 Non-Final OA 9d Pending Oct 10, 2024
18897062 SYSTEM AND METHOD FOR AUTHORIZING DATA TRANSFERS The Toronto-Dominion Bank TURCHEN, JAMES R 2439 §102§103 Non-Final OA — Pending Sep 26, 2024
18892977 INTRALUMINAL MODULAR POWERED MEDICAL SYSTEM Puzzle Medical Devices Inc. SHENG, CHAO 3797 §103 Non-Final OA — Pending Sep 23, 2024
18836968 SYSTEM AND METHOD FOR OBJECT COMPREHENSION Singulos Research Inc. MALIKASIM, JONATHAN L §101§102§103§112 Non-Final OA — Pending Aug 08, 2024
18784024 GLASS COMPOSITION Ir Scientific Inc. PETRITSCH, AMANDA MICHELLE §103DP Non-Final OA — Pending Jul 25, 2024
18728810 ANALYZER SYSTEM AND METHOD FOR REAL-TIME SYNCHRONOUS DETECTION OF THE CHARACTERISTIC NEAR-INFRARED WAVELENGTH FEATURES OF OPTICALLY ACTIVE SUBSTANCES Provincial Health Services Authority LYONS, MICHAEL A 2871 §102§112 Non-Final OA — Pending Jul 12, 2024
18703101 RECOMBINANT POLYPEPTIDE FOR DISRUPTING INTERACTION OF EAG2 AND KVß2 AND THERAPEUTIC APPLICATIONS THEREOF IN CANCER TREATMENT The Hospital for Sick Children COFFA, SERGIO §112 Final Rejection — Pending Apr 19, 2024
18701047 MICRONEEDLE AND ARRAY AND METHOD OF FABRICATING SAME UTI LIMITED PARTNERSHIP VU, QUYNH-NHU HOANG §102§103§112 Non-Final OA — Pending Apr 12, 2024
18634043 SYSTEM AND METHOD FOR DEFECT ROOT CAUSE DETERMINATION AND REPORTING IN A SOFTWARE ENVIRONMENT The Toronto-Dominion Bank SCHELL, JOSEPH O 2114 §101§103 Final Rejection 23d Pending Apr 12, 2024
18698185 SUPERSONIC FLUIDIC OSCILLATOR AND METHOD OF CONTROLLING A SUPERPLASTIC FORMING PROCESS Macrodyne Technologies Inc. ORTIZ-ORTIZ, ALONDRA MICHELLE 3725 §103§112 Non-Final OA — Pending Apr 03, 2024
18620200 SYSTEM AND METHOD FOR CREATING SERVICE PROVISIONS FOR RELATED SERVICE PRODUCTS The Toronto-Dominion Bank JUNG, HENRY H 3695 §101§103 Final Rejection — Pending Mar 28, 2024
18613216 SYSTEMS AND METHODS FOR ELECTRIC VEHICLE CHARGING OPTIMIZATION AND GRID BALANCING Bluwave Inc. KASENGE, CHARLES R 2116 §102 Non-Final OA — Pending Mar 22, 2024
18558669 EXTRACELLULAR VESICLE-DIRECTED POLYPEPTIDE TAG Ottawa Hospital Research Institute BURKHART, MICHAEL D 1638 §101§102§112 Non-Final OA 41d Pending Nov 02, 2023
18494927 METHODS AND SYSTEMS FOR CONTROLLING ELECTRIC VEHICLE CHARGING BASED ON POWER DISTRIBUTION SYSTEM INFORMATION Bluwave Inc. SANDERS, JOSHUA T 2119 §103 Non-Final OA 50d overdue Pending Oct 26, 2023
18557476 PROCESS AND REACTOR FOR REMOVING IMPURITIES FROM CARBON MATERIAL Hatch Ltd. DO, AN H 2857 §102 Non-Final OA — Pending Oct 26, 2023
18474364 SYSTEM AND METHOD FOR APPLICATION PROGRAMMING INTERFACE COMMUNICATION The Toronto-Dominion Bank NWUHA, SAMUEL OBINNA NNAJI 2194 §103 Non-Final OA — Pending Sep 26, 2023
18552476 CANNABINOID FORMULATION FOR MANAGEMENT OF DEPRESSION, ANXIETY AND PTSD, AND CANNABINOID FORMULATION AS A SLEEP AID Zyus Life Sciences Inc. CHANDRAKUMAR, NIZAL S 1625 §112 Non-Final OA — Pending Sep 26, 2023
18235469 METHOD AND DEVICE FOR SAMPLE INTRODUCTION FOR MASS SPECTROMETRY Jp Scientific Limited KALISZEWSKI, ALINA ROSE 2881 §103§112 Final Rejection 23d overdue Pending Aug 18, 2023
18346415 PERCUTANEOUS ASSEMBLY AND METHODS OF USING SAME Puzzle Medical Devices Inc. SCHERBEL, TODD J 3771 §102§103 Non-Final OA — Pending Jul 03, 2023
18343960 METHODS AND COMPOUNDS FOR DETECTION AND BINDING OF ALDEHYDES UNIVERSITY OF OTTAWA DONOHUE, SEAN R 1618 §102§103§112 Final Rejection 15d Pending Jun 29, 2023
18344138 FREQUENCY AGILE BAND SELECT FILTER Nanowave Technologies Inc. SHERIF, FATUMA G 2649 §103 Final Rejection — Pending Jun 29, 2023
18255113 METHOD FOR PREIMPLANTATION GENETIC SCREENING OF EMBRYOS Reprobiogen Inc. BUCHANAN, BAILEY CHEYENNE 1682 §103 Final Rejection 34d Pending May 31, 2023
18326537 SYSTEM AND METHOD FOR PROVIDING CYBERSECURITY SIMULATION AND TRAINING Beauceron Security Inc. BIANCAMANO, ALYSSA N 3715 §101§112 Final Rejection 27d Pending May 31, 2023
18042145 DUAL ANALGESIC/ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CB2 RECEPTOR AGONISTS, COMBINATIONS, AND METHODS OF USE THEREOF Altus Formulation Lnc. KASSA, TIGABU 1619 §102§103§112 Non-Final OA — Pending Feb 17, 2023
18015634 METHOD AND APPARATUS FOR DETERMINING BIOMARKERS OF VASCULAR FUNCTION UTILIZING BOLD CMR IMAGES Area 19 Medical Inc. BRUCE, FAROUK A 3797 §103 Non-Final OA 39d Pending Jan 11, 2023
17990322 IMPLANTABLE FULLY ENDOVASCULAR MAMMALIAN BODY SUCCEDENT CAVITY WALL BREACH SEALING DEVICE Puzzle Medical Devices Inc. DORNBUSCH, DIANNE 3771 §102§103 Final Rejection 43d overdue Pending Nov 18, 2022
17979350 METAL-DISSOLVING APPARATUS, PROCESSES AND USES THEREOF Hatch Ltd. PULLEN, NIKOLAS TAKUYA 1733 §102§103§112 Final Rejection 15d Pending Nov 02, 2022
17979502 PROCESS AND APPARATUS FOR REMOVING IMPURITIES FROM CRYSTALLIZED METAL SULFATES Hatch Ltd. DAVIS, SHENG HAN 1732 §103 Non-Final OA — Pending Nov 02, 2022
17960189 SYSTEM AND METHOD FOR PROVIDING MULTI-CHANNEL AUTHENTICATION The Toronto-Dominion Bank SHAUGHNESSY, AIDAN EDWARD 2432 §103 Non-Final OA 9d Pending Oct 05, 2022
17837463 SYSTEM AND METHOD FOR ASSISTING FLOW OF A FLUID IN A VASCULAR SYSTEM OF A MAMMALIAN BODY Puzzle Medical Devices Inc. MANNAN, MIKAIL A 3774 §102§103 Final Rejection — Pending Jun 10, 2022
17602205 RADIOPAQUE GLASS MATERIAL Abk Biomedical Incorporated WESTERBERG, NISSA M 1618 §103§112 Non-Final OA 126d overdue Pending Oct 07, 2021
16981835 MULTIFUNCTIONAL COATINGS FOR USE IN WET ENVIRONMENTS Graphite Innovation And Technologies Inc. BUTCHER, ROBERT T 1764 §103 Final Rejection 57d Pending Sep 17, 2020

Managing Borden Ladner Gervais LLP (Ottawa)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month